After inflammation, fibrosis: Will biopharma follow nature’s lead?

PDF
Moderators:

  • David J. Lomb – Senior Consultant, Defined Health

Panelists:

  • Matthias Corbascio – VP, Inflammation, IsletOne Therapeutics
  • Donnie McGrath – VP, Search and Evaluation, Business Development, Bristol-Myers Squibb
  • Elias Papatheodorou – CEO, Genkyotex S.A
  • Hans T. Schambye – CEO, Galecto Biotech AB